Artificial Intelligence-based Digital Pathology Assessment of CD44s Expression in Breast Cancer
Breast cancer (BC) exhibits considerable molecular and clinical heterogeneity, complicating prognostic evaluation. The cluster of differentiation 44 standard (CD44s) isoform has been proposed as a prognostic marker in various cancers; however, its role in BC remains unclear. This study evaluated CD...
Saved in:
| Main Authors: | Avan S. Mohammed, Ramadhan T. Othman, Rafil T. Yaqo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Koya University
2025-06-01
|
| Series: | ARO-The Scientific Journal of Koya University |
| Subjects: | |
| Online Access: | https://88.198.206.215/index.php/aro/article/view/2248 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aldehyde dehydrogenase 1 and CD44 serve as prognostic markers in patients with breast cancer
by: Ayan Pradhan, et al.
Published: (2022-09-01) -
EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
by: S. G. Smirnova, et al.
Published: (2020-09-01) -
The TIP60-CD44 Axis Modulates Colorectal Cancer Stemness
by: Asad Mohammad, et al.
Published: (2025-05-01) -
Hyaluronic acid-engineered milk extracellular vesicles to target triple negative breast cancer through CD44
by: Filipa A. Soares, et al.
Published: (2025-12-01) -
FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01)